The forthcoming programme at EANS2018 demonstrates that Zeiss are active and will have Kinevo and Convivo on show together. Scientific papers show where Convivo is available for use to a growing scientific audience. Medical companies are adept at marketing "subject to FDA approval". I am less concerned about the actions of Zeiss than I am about the actions of a BOD which hasn't even mentioned EANS2018 in Brussels and where the last news item on the wesite is October, 2017.
The forthcoming programme at EANS2018 demonstrates that Zeiss...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
